InfuSystem Announces Financial Results for Second Quarter 2026
Business Wire (Tue, 4-Aug 6:30 AM ET)
InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026
Business Wire (Tue, 28-Jul 6:30 AM ET)
Market Chameleon (Tue, 19-May 6:33 AM ET)
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Infusystems Holdings trades on the AMEX stock market under the symbol INFU.
As of August 31, 2026, INFU stock price climbed to $12.15 with 76,900 million shares trading.
INFU has a beta of 0.90, meaning it tends to be less sensitive to market movements. INFU has a correlation of 0.04 to the broad based SPY ETF.
INFU has a market cap of $241.99 million. This is considered a Small Cap stock.
Last quarter Infusystems Holdings reported $37 million in Revenue and $.15 earnings per share. This beat revenue expectation by $550,600 and exceeded earnings estimates by $.04.
In the last 3 years, INFU traded as high as $12.97 and as low as $4.61.
The top ETF exchange traded funds that INFU belongs to (by Net Assets): AVUV, IWM, VTI, IWO, VXF.
INFU has underperformed the market in the last year with a return of +13.2%, while SPY returned +19.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in INFU shares. However, INFU has outperformed the market in the last 3 month and 2 week periods, returning +34.1% and -1.0%, while SPY returned +1.9% and -1.2%, respectively. This indicates INFU has been having a stronger performance recently.
INFU support price is $11.71 and resistance is $12.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INFU shares will trade within this expected range on the day.